Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of AAR Corp. (NYSE:AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

AAR reported quarterly sales of $545.4 million, up 16% Y/Y, missing the consensus of $557.2 million. Adjusted EPS from continuing operations rose 17% Y/Y to 81 cents, beating the consensus of 80 cents.

AAR recently disclosed the buyout of the Product Support business of Triumph Group Inc (NYSE:TGI) for $725 million.

AAR shares fell 7% to $65.82 on Friday.

Here are some other stocks moving in today's mid-day session.

Gainers

• NextPlay Technologies, Inc. (NASDAQ:NXTP) shares jumped 263% to $3.29.
• Jin Medical International Ltd. (NASDAQ:ZJYL) gained 71% to $120.50.
• Daseke, Inc. (NASDAQ:DSKE) gained 64.8% to $8.10 after the company announced it will be acquired by TFI International.
• Royalty Management Holding Corporation (NASDAQ:RMCO) jumped 59% to $3.18. Royalty Management Holding announced that Ferrox Holdings confirmed the commencement of production of titanium ferrite from its Tivani operating site.
• Karuna Therapeutics, Inc. (NASDAQ:KRTX) shares gained 46.9% to $316.20. Bristol Myers Squibb & Co (NYSE:BMY) agreed to acquire Karuna Therapeutics for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired.
• Polished.com Inc. (NYSE:POL) rose 46% to $5.91.
• Esports Entertainment Group, Inc. (NASDAQ:GMBL) jumped 40.8% to $5.92.
• Argo Blockchain plc (NASDAQ:ARBK) gained 35% to $3.4801.
• PureTech Health plc (NASDAQ:PRTC) climbed 33.8% to $24.95 after the company announced that its Founded Entity, Karuna Therapeutics, entered into a definitive merger agreement to be acquired by Bristol Myers Squibb.
• Snow Lake Resources Ltd. (NASDAQ:LITM) rose 29.6% to $1.1389.
• Asset Entities Inc. (NASDAQ:ASST) rose 25.9% to $0.8310 after jumping 45% on Thursday. Asset Entities, last month, announced a stock repurchase program.
• Rocket Lab USA, Inc. (NASDAQ:RKLB) shares gained 25% to $5.54 after the company announced a new $515 million contract with a U.S. government customer.
• Enlivex Therapeutics Ltd. (NASDAQ:ENLV) rose 23.6% to $2.8150. Enlivex Therapeutics recently announced that it completed enrollment of all 120 patients in its Phase II trial of Allocetra in patients with sepsis.
• Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares rose 22.4% to $0.5466 after the company announced the closing of the expanded global partnership with Pierre Fabre Laboratories for tabelecleucel.
• Neumora Therapeutics, Inc. (NASDAQ:NMRA) surged 20.2% to $16.81.
• Canaan Inc. (NASDAQ:CAN) gained 20% to $3.10.
• Wheels Up Experience Inc. (NYSE:UP) rose 19.3% to $3.2801.
• Bitdeer Technologies Group (NASDAQ:BTDR) gained 16.6% to $9.85.
• MoneyLion Inc. (NYSE:ML) surged 14.6% to $64.42.
• Tourmaline Bio, Inc. (NASDAQ:TRML) rose 14.3% to $23.01.
• ALX Oncology Holdings Inc. (NASDAQ:ALXO) jumped 13.6% to $14.81.
• Allogene Therapeutics, Inc. (NASDAQ:ALLO) gained 13.5% to $3.1333.
• Mineralys Therapeutics, Inc. (NASDAQ:MLYS) rose 13% to $8.44. Mineralys said first subject dosed in Launch-HTN, the second pivotal trial of lorundrostat for treatment of hypertension.
• ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) surged 11.5% to $11.71.
• Jin Medical International Ltd. (NASDAQ:ZJYL) gained 11.5% to $78.62.
• ImmunityBio, Inc. (NASDAQ:IBRX) shares rose 11.2% to $4.5350 after declining 10% on Thursday.
• Apogee Therapeutics, Inc. (NASDAQ:APGE) jumped 10.3% to $28.17.
• ANSYS, Inc. (NASDAQ:ANSS) gained 10.2% to $334.05.
• Fulcrum Therapeutics, Inc. (NASDAQ:FULC) rose 10.2% to $6.36.
• Prime Medicine, Inc. (NASDAQ:PRME) gained 9% to $9.55.
• Compass, Inc. (NYSE:COMP) gained 8.7% to $3.50.
• Altair Engineering Inc. (NASDAQ:ALTR) surged 8.3% to $80.95 after JP Morgan initiated coverage on the stock with an Overweight rating and $86 price target.

Losers

• AlloVir, Inc. (NASDAQ:ALVR) shares dipped 66.1% to $0.7904 after the company provided an update on its three Phase 3 clinical trials with posoleucel, an investigational off-the-shelf multi-virus-specific T cell therapy, which targets six viral pathogens in immunocompromised individuals: adenovirus (AdV), BK virus (BKV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus-6 (HHV-6) and JC virus (JCV).
• Jayud Global Logistics Limited (NASDAQ:JYD) fell 46% to $1.49.
• Netcapital Inc. (NASDAQ:NCPL) shares fell 36% to $0.2114 after the company announced pricing of a $4 million public offering.
• Advent Technologies Holdings, Inc. (NASDAQ:ADN) shares fell 34.2% to $0.2050 after announcing a $2 million registered direct offering of common stock.
• Banyan Acquisition Corporation (NYSE:BYN) fell 28.5% to $7.79.
• ParaZero Technologies Ltd. (NASDAQ:PRZO) dipped 27% to $1.1700.
• Linkage Global Inc (NASDAQ:LGCB) fell 24.4% to $1.77. Linkage Global recently priced $6 million initial public offering of 1.5 million ordinary shares at $4 per share.
• Cemtrex, Inc. (NASDAQ:CETX) fell 20.3% to $5.18 following quarterly results.
• ATIF Holdings Limited (NASDAQ:ATIF) dipped 20% to $0.8390.
• Lottery.com Inc. (NASDAQ:LTRY) fell 18% to $3.01.The company’s shares jumped 196% on Thursday after the company announced an $18 million investment commitment from Prosperity Investment Management.
• 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares fell 17.3% to $0.9103 after declining around 6% on Thursday.
• Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell 17.1% to $2.9850 after the company announced a registered direct and private placement offering priced at-the-market under Nasdaq rules.
• Brooge Energy Limited (NASDAQ:BROG) fell 16.4% to $3.3590.
• Mullen Automotive, Inc. (NASDAQ:MULN) shares fell 15.9% to $11.98. Mullen Automotive shares jumped 78% on Thursday amid increased volatility following the company's 1-for-100 reverse split, and after the company announced 38 additional Class 3 vehicles have been delivered to Randy Marion Automotive Group with the company invoicing RMA for $2.5 million.
• NetEase, Inc. (NASDAQ:NTES) fell 14.9% to $88.81 after China unveiled draft rules aimed at curbing spending on online gaming.
• Nanobiotix S.A. (NASDAQ:NBTX) shares declined 13.8% to $6.62 after jumping more than 15% on Thursday.
• NIKE, Inc. (NYSE:NKE) shares fell 10.8% to $109.31. NIKE posted better-than-expected earnings for its second quarter, but sales missed expectations. The company also stated that it is assessing opportunities to deliver up to $2 billion in cumulative cost savings during the next three years.
• HUYA Inc. (NYSE:HUYA) shares declined 9.8% to $3.2750. HUYA entered into definitive agreement to acquire a global mobile application service provider.
• Foot Locker, Inc. (NYSE:FL) declined 5.5% to $30.54. Shares of footwear and athletic apparel stocks traded lower in sympathy with Nike, which fell after reporting mixed second-quarter results, lowering its outlook and announcing cost savings plans.

Now Read This: Ethereum Hits $2,300 Following PCE Data; Optimism Emerges As Top Gainer